Loading
Plant Advanced Technologies PAT Stock: price and insider trades · France
No insider purchase over the last 90 days. The latest, by QUANTITATIS (ANCIEN) SARL, was filed 26 Dec 2025.
Plant Advanced Technologies PAT: what insiders have been doing
This page follows insider dealings at Plant Advanced Technologies PAT as filed with AMF, a company from the Healthcare & Pharma sector. Between 23 October 2025 and 23 October 2026, 4 insiders published 47 filings.
Open-market activity splits into 19 purchases totalling €2,125 and 28 sales totalling €111k; 4 insiders sit on the buying side and 4 insiders on the selling side. Taken together, the sales exceed the purchases by €109k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 3 chief executives and 1 board member. At €15k, the sale published on 7 November 2025 by Jean-Paul FEVRE is the largest of the period.
Within a 30-day window, 1 purchase overlapped with buying by a second insider. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The last purchase on record was published on 26 December 2025, which is 301 days ago. Typically, a trade is published a median of 49 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Compared with its exchange (313 companies, median 7 filings), a count of 47 filings is above the norm. The full history, which starts in 2021, counts 22 purchases against 34 sales.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.
Insider Decl.
56
Thresholds
n/a
Buy Volume
€111,372
22 ops. · all time
Sell Volume
€341,887
34 ops. · all time
Who traded when
BuySaleFrédéric Bourgaud12 buys22 sales
Jean-Paul FEVRE4 buys4 sales
Quantitatis (Ancien) Sarl3 buys3 sales
Quantitatis Sarl1 buy2 sales
Since the insiders bought
- -53.0%Entry €8.38 · Close 22 Oct 2026 €3.94
- -53.2%Entry €8.42 · Close 22 Oct 2026 €3.94
- -53.1%Entry €8.40 · Close 22 Oct 2026 €3.94
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fundamental score
Ranked 5,758 of 26,250 companies
65.9
score / 100
Value78
Quality54
FCF yld46%
Earn yld12%
EV/EBITDA11.9x
ROE5.9%
Gross mgn·
Net mgn50%
Debt/EBITDA5.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended December 2024 · cache
€4.00
Analyst consensus
Income statement
Revenue€1.1M
Gross profit€1.2M109% margin
EBITDA€695k61% margin
Net income€569k41.5% margin
Valuation
PER (trailing)7.8x
P/Book0.5x
Beta0.81
Balance sheet & cash
Market cap€4.6M
Total debt€3.7M
Free Cash Flow€2.1M
Debt / Equity37%
Profitability & ownership
ROE5.9%
ROA-1.4%
% insiders48.1%
% institutions0.0%
Last declaration on 26 December 2025
Declarations56 total
550 shares@ €8.081823.6% of flowActionEuronext Growth ParisISIN FR00107857902025DD1086337
35 shares@ €8.3714ActionEuronext Growth ParisISIN FR00107857902025DD1086337-T2
Canonical exit: 23 Mar 2026 (T+90)
726 shares@ €8.143831.4% of flowActionEuronext Growth ParisISIN FR00107857902025DD1085743
23 shares@ €8.52351.0% of flowActionEuronext Growth ParisISIN FR00107857902025DD1085743-T2
Canonical exit: 19 Mar 2026 (T+90)
1,140 shares@ €8.2131100.0% of flowActionEuronext Growth ParisISIN FR00107857902025DD1075204
115 shares@ €8.149.1% of flowActionEuronext Growth ParisISIN FR00107857902025DD1075204-T3
25 shares@ €8.316ActionEuronext Growth ParisISIN FR00107857902025DD1075204-T2
Canonical exit: 15 Mar 2026 (T+90)
10 shares@ €8.540.0% of flowActionEuronext Growth ParisISIN FR00107857902025DD1075208
Canonical exit: 15 Mar 2026 (T+90)
10 shares@ €8.400.0% of flowActionEuronext Growth ParisISIN FR00107857902025DD1075208-T2
Canonical exit: 16 Mar 2026 (T+90)
276 shares@ €8.655.2% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068555
342 shares@ €8.556.4% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068556
218 shares@ €8.414.0% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068558
774 shares@ €8.3014.0% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068561
171 shares@ €8.6943.2% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068490
272 shares@ €8.62495.1% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068498
131 shares@ €8.71561.3% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068498-T2
305 shares@ €8.61123.1% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068498-T3
504 shares@ €8.80165.2% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068498-T4
74 shares@ €8.821.4% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068534
6 shares@ €9.080.1% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068534-T9
Canonical exit: 23 Dec 2025 (T+90)
9 shares@ €9.04670.1% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068534-T10
Canonical exit: 22 Dec 2025 (T+90)
723 shares@ €8.84259.1% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068534-T2
671 shares@ €8.82638.4% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068534-T3
359 shares@ €9.004.6% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068534-T4
4 shares@ €8.900.1% of flowActionEuronext Growth ParisISIN FR00107857902025DD1068534-T7
Canonical exit: 25 Dec 2025 (T+90)
25 of 56 declarations
About Plant Advanced Technologies PAT
Plant Advanced Technologies PAT is a French plant-biotechnology company listed on Euronext Growth Paris under ISIN FR0010785790 (ticker ALPAT). Founded in June 2005 in Nancy, the company was originally created to develop and industrialize the PAT plantes à traire® technology, which was built on research from the Institut National Polytechnique de Lorraine and INRA. Since then, PAT has established itself in a highly specialized niche focused on the discovery, optimization and industrial production of rare plant biomolecules that have traditionally been difficult to source at scale.
PAT’s core business is the development of plant-derived active ingredients for the cosmetics, pharmaceutical and agrochemical industries, with an expanding presence in nutraceuticals and fine chemicals. The group emphasizes exclusive, high-value solutions that combine innovation, traceability and control over the full value chain, from the plant to the final product. Its technological platform includes proprietary approaches such as PAT plantes à traire® and PAT Friday®, as well as metabolic engineering and microbial fermentation through its Cellengo subsidiary.
Read moreShow less
Over time, PAT has built a diversified scientific and industrial platform. In cosmetics, it regularly launches new active ingredients and works with industrial partners. In pharmaceuticals, its Temisis subsidiary is focused on small molecules with notable anti-inflammatory potential. In agrochemistry, PAT develops and tests molecules for crop protection. The group also owns StratiCell, which provides cosmetic efficacy and safety testing, and Couleurs de Plantes, which specializes in plant-based colorants. These assets broaden PAT’s commercial reach while leveraging the same underlying scientific expertise.
From a market positioning standpoint, PAT is best described as an innovation-driven niche specialist rather than a large-scale industrial supplier. Its competitive strength lies in scarce active ingredients, a sizeable intellectual-property portfolio, and a strong scientific workforce of more than 60 employees, roughly two-thirds of whom are dedicated to R&D. The company also highlights its sustainability credentials, including a 2024 EcoVadis Gold medal.
Financially, PAT reached an important milestone in 2024 by posting its first operating profit since inception, at €215k, on revenue of €1.927 million. In the first half of 2025, revenue stood at €155k in a seasonal business context, while debt continued to decline and management reiterated its goal of generating a third consecutive full-year profit. Headquartered in Vandœuvre-lès-Nancy, the group maintains an operational and partnership footprint in France and Belgium, while targeting international markets through collaborations and patented technologies.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
